Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$464M |
| 2 |
West Pharmaceutical
WST
|
+$440M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$395M |
| 4 |
JPMorgan Chase
JPM
|
+$366M |
| 5 |
Costco
COST
|
+$283M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Colgate-Palmolive
CL
|
+$612M |
| 2 |
Apple
AAPL
|
+$402M |
| 3 |
Hubbell
HUBB
|
+$281M |
| 4 |
Automatic Data Processing
ADP
|
+$246M |
| 5 |
Ecolab
ECL
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.77% |
| 2 | Healthcare | 15.04% |
| 3 | Financials | 12.69% |
| 4 | Industrials | 9.18% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3976
CALL
Carnival Corporation Ltd
CCL
$38.9B
| $80.6K | ﹤0.01% |
10,000
| – | – |
|
|
FRGE
3977
DELISTED
Forge Global Holdings
FRGE
| $80.2K | ﹤0.01% |
3,092
-3,271
| -51% | -$74.4K |
|
|
TCN
3978
DELISTED
Tricon Residential Inc.
TCN
| $80K | ﹤0.01% |
10,379
+1
| +0% | +$8 |
|
3979
Atossa Therapeutics
ATOS
$25.5M
| $80K | ﹤0.01% |
10,085
-52
| -0.5% | -$597 |
|
3980
Savara
SVRA
$1.08B
| $79.4K | ﹤0.01% |
51,222
-34,956
| -41% | -$47.9K |
|
|
CBIO
3981
Crescent Biopharma
CBIO
$618M
| $79.3K | ﹤0.01% |
262
| – | – |
|
3982
Oric Pharmaceuticals
ORIC
$1.42B
| $78.4K | ﹤0.01% |
13,309
| – | – |
|
3983
BlackBerry
BB
$5.27B
| $78.3K | ﹤0.01% |
24,031
-547,222
| -96% | -$2.43M |
|
3984
Diana Shipping
DSX
$307M
| $78K | ﹤0.01% |
25,073
-1
| -0% | -$3 |
|
3985
Comscore
SCOR
$91.6M
| $77.9K | ﹤0.01% |
3,356
-15
| -0.4% | -$389 |
|
|
SNCE
3986
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $76.7K | ﹤0.01% |
9,234
-307
| -3% | -$6.01K |
|
|
MRNS
3987
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $76.1K | ﹤0.01% |
19,117
-365
| -2% | -$1.79K |
|
3988
Twin Disc
TWIN
$349M
| $74.9K | ﹤0.01% |
7,706
-13
| -0.2% | -$138 |
|
|
CARM
3989
DELISTED
Carisma Therapeutics
CARM
| $74.5K | ﹤0.01% |
6,110
| – | – |
|
|
RPT
3990
Rithm Property Trust
RPT
$101M
| $73.7K | ﹤0.01% |
1,695
-17
| -1% | -$794 |
|
|
DMTK
3991
DELISTED
DermTech, Inc. Common Stock
DMTK
| $73.4K | ﹤0.01% |
41,479
+29,327
| +241% | +$78K |
|
3992
Equinox Gold
EQX
$13.1B
| $73.2K | ﹤0.01% |
22,331
-1,305
| -6% | -$4.5K |
|
3993
Redwire
RDW
$3.3B
| $72.7K | ﹤0.01% |
36,724
+3,237
| +10% | +$7.46K |
|
|
HYPD
3994
Hyperion DeFi Inc
HYPD
$42.9M
| $72.3K | ﹤0.01% |
555
-14
| -2% | -$2.21K |
|
3995
American Resources Corp
AREC
$302M
| $71.1K | ﹤0.01% |
53,866
-225
| -0.4% | -$411 |
|
3996
IRIDEX
IRIX
$14.3M
| $69.7K | ﹤0.01% |
34,693
| – | – |
|
3997
Invesco Senior Income Trust
VVR
$459M
| $69.6K | ﹤0.01% |
+18,164
| New | +$69.1K |
|
3998
TeraWulf
WULF
$8.14B
| $68.7K | ﹤0.01% |
103,165
-81
| -0.1% | -$81 |
|
3999
Ultralife
ULBI
$124M
| $68.6K | ﹤0.01% |
17,782
| – | – |
|
|
SOHO
4000
DELISTED
Sotherly Hotels
SOHO
| $68.6K | ﹤0.01% |
37,915
-233
| -0.6% | -$465 |
|
Similar funds
Bank of New York Mellon's Q4 2022 Portfolio in Review
As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
- Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
- Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
- Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
- Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
- Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
- Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.